Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male ratsJonas Petersen et al.2m agomedicinemetabolismobesitypharmacology
Supramolecular janus eutectic engineered from panthenol and bisabolol overcomes transdermal delivery paradoxesHao WANG et al.6d agobiomaterialschemistrymaterialspolymers
RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone lossAdel Ersek et al.8d agoagingmedicineosteoporosispharmacology
HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicityBenay Eksi et al.10d ago
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomesKatherine R. Tuttle et al.10d agocardiologyinfectious-diseasemedicine
Identifying a broad-spectrum influenza inhibitor that blocks multiple functions of viral NS1 proteinYang Zhang et al.13d agoinfectious-diseasemedicinepharmacologyvaccines
Autistic neural ‘shiftability’: the distinct pharmacological landscape of the autistic brainTobias P. Whelan et al.15d agoneuropharmacologyneuroscience
An enantioselective covalent inhibitor of BAX confers cytoprotection in vivoPeiwen Shi et al.17d agobiochemistrybiologygene-therapymedicineoncology
Author Correction: The TRPM7 chanzyme in smooth muscle cells drives abdominal aortic aneurysm in miceXuan Wang et al.20d ago
Molecular basis of diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptor C3aRSudha Mishra et al.20d agomedicinepharmacology
Structure-guided allosteric modulation of the delta opioid receptorJesse I. Mobbs et al.23d agobiologymedicineopioid-receptorspharmacologystructural-biology
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careMauro Pettorruso et al.26d agoemotionmedicinepsychiatrypsychology
Antidepressant-like effects of ketamine involve CX3CL1/CX3CR1 signaling-mediated synaptic plasticity in the mPFCYong-Yu Yin et al.26d agomedicineneuropharmacologypsychiatrypsychology
Quantification of drug rebinding at dopamine D2 receptor-expressing cell membranes with implications for extrapyramidal side effectsHannah J. Lockington et al.26d agomedicineneuropharmacologypsychiatrypsychology
From cabozantinib to zanzalintinib: obvious chemical modifications as a new frontier in product hoppingGarth W. Strohbehn et al.8/12/2026
Association between clozapine-induced hypertriglyceridemia and defenestration of liver sinusoidal endothelial cellsTetyana Voloshyna et al.8/7/2026
MODEL-informed nivolumab less frequent dosing using virtual patients with solid tumorsHongjae Lee et al.8/5/2026medicineoncology
A canonical microcircuit for estimating Excitation/Inhibition (E/I) balanceDaniel J. Hauke et al.8/1/2026
Cardioprotective properties of empagliflozin and other SGLT2 inhibitorsThomas A. Zelniker et al.7/28/2026cardiologymedicinepharmacology